scholarly journals Evidence-based non-pharmacological treatment of osteoarthritis

2021 ◽  
Vol 67 (2) ◽  
Author(s):  
Jemma E Reid ◽  
Samar Reghunandanan ◽  
Ann Roberts ◽  
Naomi A Fineberg

This chapter reviews standard pharmacological treatments for OCD and the evidence supporting them. Selective serotonin reuptake inhibitors (SSRIs) remain the pharmacological treatment of choice and are associated with improved health-related quality of life. Improvements are usually sustained over time as long as treatment is continued. Discontinuation is associated with relapse and loss of quality of life, implying that treatment should continue long-term. A substantial minority of patients who fail to respond to SSRIs may benefit from dose elevation, switch to clomipramine, or adjunctive antipsychotic, though long-term trials validating the effectiveness and tolerability of these strategies are relatively lacking.


2017 ◽  
Vol 41 (S1) ◽  
pp. S33-S33
Author(s):  
A. Philipsen

Attention Deficit Hyperactivity Disorder (ADHD) is a serious risk factor for co-occurring psychiatric disorders and negative psychosocial consequences over the lifespan. Given this background, there is a need for an effective treatment of ADHD patients.In the lecture, evidence-based psychosocial interventions for ADHD will be presented.Disclosure of interestBooks and articles on ADHD.Ad Boards, Phase-III Studies on ADHD in the last five years.


2005 ◽  
Vol 20 (5-6) ◽  
pp. 431-441 ◽  
Author(s):  
B. Le Foll ◽  
P. Melihan-Cheinin ◽  
G. Rostoker ◽  
G. Lagrue ◽  

AbstractTobacco use is the leading preventable cause of death in developed countries. Millions of smokers are willing to stop, but few of them are able to do so. Clinicians should only use approaches that have demonstrated their efficacy in helping patients to stop smoking. This article summarizes the evidence-based major findings and clinical recommendations for the treatment of tobacco dependence of the French Health Products Safety Agency (AFSSAPS). Clinicians should enquire about the smoking status of each patient and provide information about health consequence of smoking and effective treatments available. These treatments include counseling (mainly individual or social support and behavioral and cognitive therapy) and pharmacological treatment with either nicotine replacement therapy (NRT) or bupropion LP. Pharmacological treatments should be used only for proven nicotine dependence, as assessed by the Fagerstrom test for Nicotine Dependence. The choice of pharmacologic treatment depends of the patient's preference and history and of the presence of contra-indications. The clinician should start with a single agent, but these treatments may be used in combination. Smoking behavior is a chronic problem that requires long-term management and follow-up. Access to intensive treatment combining pharmacological treatment and extensive behavioral and cognitive therapy should be available for highly dependent patients.


2014 ◽  
Vol 29 (1) ◽  
pp. 12 ◽  
Author(s):  
Seon-Cheol Park ◽  
Hong Seok Oh ◽  
Dong-Hoon Oh ◽  
Seung Ah Jung ◽  
Kyoung-Sae Na ◽  
...  

1999 ◽  
Vol 19 (04) ◽  
pp. 475-505 ◽  
Author(s):  
Gennaro D'Amico ◽  
Luigi Pagliaro ◽  
Jaime Bosch

Sign in / Sign up

Export Citation Format

Share Document